HHBT: AI 评分 50/100 — AI 分析 (4月 2026)

HH Biotechnology Holdings Company focuses on health and green industries, specifically the planting and supply of macadamia nuts. The company caters to various sectors, including food, cooking oils, healthy products, toiletries, and cosmetics.

Key Facts: AI Score: 50/100 Sector: Real Estate

公司概况

概要：

HH Biotechnology Holdings Company, operating in the real estate services sector, cultivates and supplies macadamia nuts for diverse applications. With a 31.0% profit margin, the company focuses on health and green industries, distinguishing itself through its agricultural focus within the real estate landscape.

HHBT是做什么的？

HH Biotechnology Holdings Company, originally incorporated in 1987 as Great China International Holdings, Inc., transitioned to its current name in August 2016 to reflect its focus on health and green industries. Headquartered in Shenyang, People's Republic of China, the company specializes in the cultivation and supply of macadamia nuts. These nuts are utilized across various sectors, including food, cooking oils, healthy products, toiletries, and cosmetics. The company's operations are centered around providing high-quality macadamia nuts to meet the growing demand for natural and healthy ingredients. With 121 employees, HH Biotechnology Holdings Company aims to capitalize on the increasing consumer interest in health-conscious products and sustainable practices. The company's strategic shift towards macadamia nut production positions it within the broader agricultural sector, aligning with the rising global demand for plant-based ingredients and natural resources.

HHBT的投资论点是什么？

HH Biotechnology Holdings Company presents a unique investment proposition within the real estate services sector due to its focus on macadamia nut cultivation. The company's 31.0% profit margin indicates operational efficiency, while its 29.5% gross margin reflects the profitability of its core business. Key value drivers include the increasing demand for macadamia nuts in various industries and the company's established presence in the Chinese market. Potential catalysts include expansion into new geographic regions and diversification of product offerings. However, the may be worth researching high beta of 4.45, indicating significant volatility, and the absence of dividends, which may deter income-seeking investors. The company's success hinges on its ability to scale production, manage costs, and navigate the competitive landscape.

HHBT在哪个行业运营？

HH Biotechnology Holdings Company operates within the real estate services sector, with a specific focus on agricultural activities related to macadamia nut production. The global macadamia market is experiencing growth driven by increasing demand for healthy snacks, plant-based ingredients, and natural cosmetics. The competitive landscape includes agricultural companies, food producers, and cosmetic manufacturers. HH Biotechnology Holdings Company differentiates itself through its specialization in macadamia nuts and its presence in the Chinese market. The company's success depends on its ability to compete with larger agricultural players and capitalize on the growing demand for macadamia nuts in various industries.

Real Estate - Services

Real Estate

HHBT有哪些增长机遇？

Expansion into international markets: HH Biotechnology Holdings Company can explore opportunities to export macadamia nuts to countries with high demand for healthy snacks and plant-based ingredients. The global macadamia market is projected to reach $2.15 billion by 2028, presenting a significant growth opportunity. Timeline: 2-3 years.
Diversification of product offerings: The company can expand its product line to include macadamia nut-based products such as macadamia oil, macadamia butter, and macadamia flour. This diversification can cater to a wider range of consumer preferences and increase revenue streams. The market for plant-based products is growing rapidly, with a projected value of $74.2 billion by 2027. Timeline: 1-2 years.
Strategic partnerships with food and cosmetic companies: HH Biotechnology Holdings Company can collaborate with food and cosmetic manufacturers to supply macadamia nuts for their products. These partnerships can provide a stable demand for the company's macadamia nuts and increase its market reach. The food and cosmetic industries are increasingly seeking natural and sustainable ingredients, creating opportunities for macadamia nut suppliers. Timeline: 1 year.
Investment in research and development: The company can invest in research and development to improve macadamia nut yields, develop new macadamia nut varieties, and enhance the quality of its products. This can provide a competitive advantage and increase the value of its macadamia nuts. The agricultural technology market is growing rapidly, with a projected value of $30.9 billion by 2025. Timeline: Ongoing.
Implementation of sustainable farming practices: HH Biotechnology Holdings Company can adopt sustainable farming practices to reduce its environmental impact and appeal to environmentally conscious consumers. This can enhance the company's reputation and attract customers who prioritize sustainability. The market for sustainable products is growing rapidly, with a projected value of $150 billion by 2021. Timeline: Ongoing.

Profit Margin of 31.0% indicates strong operational efficiency.
Gross Margin of 29.5% reflects the profitability of macadamia nut cultivation.
Beta of 4.45 suggests high volatility compared to the market.
Focus on health and green industries aligns with growing consumer trends.
Headquartered in Shenyang, China, providing access to a large and growing market.

HHBT提供哪些产品和服务？

Cultivates macadamia nuts.
Supplies macadamia nuts to food manufacturers.
Provides macadamia nuts for cooking oil production.
Offers macadamia nuts for healthy product formulations.
Supplies macadamia nuts for toiletries and cosmetics.
Focuses on health and green industries.

HHBT如何赚钱？

Cultivation and harvesting of macadamia nuts.
Sale of macadamia nuts to various industries.
Revenue generation through product sales.
Focus on sustainable and environmentally friendly practices.

Food manufacturers.
Cooking oil producers.
Healthy product companies.
Toiletries and cosmetics manufacturers.

Specialization in macadamia nut cultivation.
Established presence in the Chinese market.
Focus on health and green industries.
Potential for sustainable farming practices.

什么因素可能推动HHBT股价上涨？

Upcoming: Potential expansion into international markets within 2-3 years.
Upcoming: Diversification of product offerings within 1-2 years.
Ongoing: Strategic partnerships with food and cosmetic companies within 1 year.
Ongoing: Investment in research and development to improve macadamia nut yields.
Ongoing: Implementation of sustainable farming practices to reduce environmental impact.

HHBT的主要风险是什么？

Potential: Competition from larger agricultural companies.
Potential: Fluctuations in macadamia nut prices.
Potential: Changes in consumer preferences.
Potential: Economic downturns.
Ongoing: Limited financial disclosure due to OTC Other listing.

HHBT的核心优势是什么？

Specialization in macadamia nut cultivation.
Established presence in the Chinese market.
Focus on health and green industries.
Profit Margin of 31.0%.

HHBT的劣势是什么？

High beta of 4.45.
Lack of dividend payments.
Limited geographic diversification.
Small number of employees (121).

HHBT有哪些机遇？

Expansion into international markets.
Diversification of product offerings.
Strategic partnerships with food and cosmetic companies.
Investment in research and development.

HHBT面临哪些威胁？

Competition from larger agricultural companies.
Fluctuations in macadamia nut prices.
Changes in consumer preferences.
Economic downturns.

HHBT的竞争对手是谁？

American Cannabis Company, Inc. — Focuses on cannabis industry. — (ACAN)
Agrotech Corp. — Focuses on agricultural technology. — (AGTK)
Braemar Hotels & Resorts Inc. — Focuses on hotel and resort properties. — (BRER)
Cowboy Properties Inc. — Focuses on real estate development. — (COWPP)
Core One Labs Inc. — Focuses on research and development. — (CRXPF)

Key Metrics

MoonshotScore: 50/100

Company Profile

CEO: Sheng Jiang
Headquarters: Shenyang, CN
Employees: 121
Founded: 2005

AI Insight

AI analysis pending for HHBT

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does HH Biotechnology Holdings Company do?

HH Biotechnology Holdings Company cultivates and supplies macadamia nuts for various industries, including food, cooking oils, healthy products, toiletries, and cosmetics. The company focuses on health and green industries, aiming to capitalize on the growing demand for natural and sustainable ingredients. Headquartered in Shenyang, China, HH Biotechnology Holdings Company operates within the real estate services sector, with a specific focus on agricultural activities related to macadamia nut production. The company's business model revolves around cultivating, harvesting, and selling macadamia nuts to various industries.

What do analysts say about HHBT stock?

AI analysis is pending for HHBT, so there is no current analyst consensus available. Key valuation metrics to consider include the company's profit margin of 31.0% and gross margin of 29.5%. Growth considerations include the increasing demand for macadamia nuts in various industries and the company's potential for expansion into new markets. Investors should also consider the high beta of 4.45, indicating significant volatility, and the absence of dividends. Further analysis is needed to assess the company's long-term prospects.

What are the main risks for HHBT?

The main risks for HH Biotechnology Holdings Company include competition from larger agricultural companies, fluctuations in macadamia nut prices, and changes in consumer preferences. The company's reliance on macadamia nut cultivation makes it vulnerable to price volatility and market demand shifts. Additionally, the company's OTC Other listing entails risks related to limited financial disclosure, low liquidity, and lack of regulatory oversight. Economic downturns could also negatively impact the demand for macadamia nuts and the company's financial performance. Investors should carefully consider these risks before investing in HHBT.